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Case Presentation
A 71-year-old Caucasian man with neurofibromatosis type 1 
(NF1) attended our skin cancer clinic for routine dermato-
oncologic follow up of primary multiple minimal invasive 
melanomas (melanoma stage IA) diagnosed during the past 
eight years.
Physical examination revealed the presence of numerous 
neurofibromas and café au lait spots on his trunk and limbs, 
as well as axillary freckles. In addition, a light brown nodule 
with a pinkish halo of 8 mm in diameter was noticed at the 
left lumbar region (Figures 1, 2). Although this lesion was 
clinically unremarkable, it differed somehow from the sur-
rounding other nodules (i.e., revealing the so-called “little red 
riding hood sign”) [1]. Upon dermoscopy, the central nodular 
part revealed brown-gray rhomboidal lines and white lines, 
whereas the pink halo exhibited small diameter, polymorphic 
microvessels and white crossing lines (Figure 3). Based on the 
dermoscopic appearance, as well as on the history of multiple 
primary melanomas, a clinical diagnosis of melanoma was 
suspected. The lesion was subsequently excised. Histopatho-
logical evaluation confirmed the clinical suspect of a focally 
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Neurofibromatosis type 1 (NF1) is a genetic disorder commonly associated with an increased risk for 
development of malignancy, including skin cancers.
Herein we describe a case of invasive melanoma occurring in a patient with NF1 and discuss the 
association between these two diseases, highlighting the importance of comparative clinical and der-
moscopic approaches in this category of patients in which the detection of melanoma can be difficult 
because of the presence of multiple skin tumors.
ABSTRACT
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phic vessels. Until future research reveals new insights into 
a potential common pathogenesis of NF1 and melanoma, 
we propose close follow-up dermatological visits of patients 
affected by NF1.
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regressive invasive melanoma (Breslow thickness 1.05 mm, 
pT2a). Imaging staging examinations revealed no evidence 
for metastases. The patient is currently scheduled for wide 
local excision and sentinel node biopsy.
Conclusion
Neurofibromatosis type 1 (NF1) is an autosomal dominant 
genetic disorder resulting from a mutation in or a deletion 
of the NF1 tumor suppressor gene on the long (q) arm of 
chromosome 17 that encodes a protein named neurofibromin 
1 [2]. A mutated form of the latter leads to a predisposition 
for malignant neoplasms, most commonly derived from the 
neural crest [3]. Melanocytes are derived from embryologic 
neural crest, so these patients can develop malignant mela-
nocytic proliferations [2,3]. Although several sporadic cases 
of patients with NF1 associated with melanoma have been 
reported in literature, the relationship between NF1 and 
melanoma is still a matter of debate [4].
Our case supports such an association, given that our 
patient suffered from seven multiple primary melanomas. 
Moreover, our case highlights the benefit of the compara-
tive approach in patients with multiple skin tumors, as the 
melanoma in our patient, albeit not evident, differed from the 
surrounding neurofibromas [5]. Finally, dermoscopy pointed 
towards the correct diagnosis of hypo- and amelanotic mela-
noma by allowing the visualization of melanoma-specific 
features such as brown-gray lines, white lines and polymor-
Figure 1. Numerous neurofibromas and one café au lait spot on the 
trunk. The black arrow indicates a light brown nodule with a pink-
ish halo. [Copyright: ©2017 Giuffrida et al.]
Figure 2. Close up of the lesion indicated by the black arrow in 
Figure 1. [Copyright: ©2017 Giuffrida et al.]
Figure 3. Dermoscopy displays brown-gray rhomboidal lines and 
white lines in the central part of the nodule and small diameter, poly-
morphic microvessels and white crossing lines in the pink halo; at 
the borders at 6 and 10 o’clock, two neurofibromas with structure-
less white to skin-colored areas are seen. [Copyright: ©2017 Giuf-
frida et al.]
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